Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Dec 5, 2024

30870_dirs_2024-12-05_f506aef9-2d6b-4aa4-add7-b984b2a9d212.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-12-03

Reporting Person: Wong Robert (VP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-03 Common Stock A 764 Acquired 18162 Direct
2024-12-03 Common Stock F 273 $51.51 Disposed 17889 Direct
2024-12-03 Common Stock A 766 Acquired 18655 Direct

Footnotes

F1: Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units ("PSUs").

F2: Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs.

F3: Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting. These PSUs to vest in full December 3, 2025.